An advanced 3D simulator to generate 3D-personalized tissue and organ models for diagnosis, planning and pre-treatment of medical vascular interventions

Projektinformationen

MedicalPhant

ID Finanzhilfevereinbarung: 816658

DOI

10.3030/816658

Projekt abgeschlossen

EK-Unterschriftsdatum 4 Mai 2018

Startdatum 1 Juni 2018

Enddatum 30 September 2018

Finanziert unter

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Gesamtkosten

€ 71 429,00

EU-Beitrag

€ 50 000,00

Koordiniert durch

VALIDA INNOVATION SOCIEDAD LIMITADA
Spain

Periodic Reporting for period 1 - MedicalPhant (An advanced 3D simulator to generate 3D-personalized tissue and organ models for diagnosis, planning and pre-treatment of medical vascular interventions)

Berichtszeitraum: 2018-06-01 bis 2018-09-30

Zusammenfassung vom Kontext und den Gesamtzielen des Projekts

Cardiovascular diseases are the first cause of deaths globally and an economic burden and they are commonly treated by surgery. However, surgeons still lack precise knowledge about what they will face in the operating room, increasing medical errors and associated morbidity and mortality. MedicalPhant is a new system for the printing of the most accurate customized 3D replicas of complex cardiovascular pathologies and structures. It uses CT/MRI/Echo images from a patient to virtual modelling and to print a 3D model with suitable materials. Our system can greatly reduce medical errors, times, hospitalization and costs of cardiac surgery and improve final outcomes, specialists’ performance and patient’s quality of life. MedicalPhant is at a TRL6, preliminary developed and validated, and now we aim to optimized it and validate it in a clinical study, scale-up the production, establish a sales team and reach potential users (hospitals, MedTech companies, etc.). We plan to obtain part of the necessary founding by applying to a H2020 SME-Instrument Phase 2 grant.

Arbeit, die ab Beginn des Projekts bis zum Ende des durch den Bericht erfassten Berichtszeitraums geleistet wurde, und die wichtigsten bis dahin erzielten Ergebnisse

Currently, we have been able to apply MedicalPhant system to produce personalized valves and specific pathologies in real cases, with a high level of detail and with their successful application in diagnosis clarification and surgery planning and training. For arteries and veins, we have fruitfully developed 3D models with the same 3-layers composition at micron thickness (not possible with existing technologies). For cardiac valves, we have developed replicas of pathologies, such as leaks, aortic fistulas, pulmonary stenosis or prolapse in mitral valve, and improved surgeries as TAVI. Also, our vascular models have been placed on a simulator with a peristaltic pump controlled by an electrical system, which simulates the heart function.

Fortschritte, die über den aktuellen Stand der Technik hinausgehen und voraussichtliche potenzielle Auswirkungen (einschließlich der bis dato erzielten sozioökonomischen Auswirkungen und weiter gefassten gesellschaftlichen Auswirkungen des Projekts)

Personalized anatomical replicas remain as a poorly exploited area of application because it is difficult to realistically mimic complex structures and tissues or obtain functional replicas. MedicalPhant is a system to produce the most similar 3D models and simulators of complex cardiovascular pathologies and structures in a personalized manner, to be used to: better understand a pathology, refine diagnosis, choose the best procedure and device/implant, better plan an intervention, practice to improve surgeon’s skills, avoid errors and reduce risks, reduce surgery time and related costs, improve post-surgery recovery and benefit all players in the healthcare system.

Valida Innovation Logo